Products
Online Inquiry
NVP-BSK805 2HCl
Cat. No.:
OB0225WX-2510
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
NVP-BSK805 2HCl is a potent, ATP-competitive JAK2 inhibitor (IC50: 0.5 nM) that displays more than 20-fold selectivity over other JAK family members such as JAK1, JAK3, and TYK2.
Synonym:
BSK805; 1092499-93-8 (free base); NVP-BSK805 dihydrochloride; BSK805; NVP-BSK805 (hydrochloride); NVP-BSK805 (dihydrochloride); 4-[[2,6-difluoro-4-[3-(1-piperidin-4-ylpyrazol-4-yl)quinoxalin-5-yl]phenyl]methyl]morpholine;dihydrochloride; 8-[3,5-Difluoro-4-(4-morpholinylmethyl)phenyl]-2-[1-(4-piperidinyl)-1H-pyrazol-4-yl]quinoxaline dihydrochloride; BSK 805; JAK2 inhibitor; NVP-BSK805 2HCl (BSK-805); 8-(3,5-difluoro-4-(morpholinomethyl)phenyl)-2-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxaline dihydr; 8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]-2-[1-(piperidin-4-yl)pyrazol-4-yl]quinoxaline dihydrochloride; AS-16275; 4-(2,6-Difluoro-4-(3-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxalin-5-yl)benzyl)morpholine dihydrochloride; 4-[[2,6-Difluoro-4-[3-(1-piperidin-4-ylpyrazol-4-yl)quinoxalin-5-yl]phenyl]methyl]morpholine dihydrochloride; 8-{3,5-Difluoro-4-[(morpholin-4-yl)methyl]phenyl}-2-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]quinoxaline--hydrogen chloride (1/2)
CAS No.:
1092499-93-8 (free base)
Compound CID:
57339395
Formula:
C27H28F2N6O·2HCl
Formula Weight:
563.47
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
NVP-BSK805 2HCl is applied in hematology research as a potent and selective JAK2 inhibitor to investigate the suppression of STAT5 phosphorylation in models of myeloproliferative neoplasms.
Library Information
Target:
JAK
Receptor:
JAK2
Pathways:
JAK/STAT
Plate Number:
L6700-04
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
113 mg/mL; 200.54 mM
Water Max Solubility:
3 mg/mL; 5.32 mM
ALogP:
3.92
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
5





